Clinical Trial Update: Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine to prevent intravesical recurrence of urothelial cancer in patients with upper tract urothelial cancer undergoing radical n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Pelvis Cancer
• Ureter Cancer
• Urothelial Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Mayo Clinic | Conditions: Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2023-08-08